In collaboration with the Lin and Stitziel labs, we applied our biophysical tools to study a de novo variant found in a patient with heart failure. We show how these tools can be used to provide insights into the potential pathogenicity of rare variants and harnessed to identify potential precision medicine therapeutics. The paper can be found here.